🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Meningioma

Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles) NCT04427384n/a54 sites📍 Phoenix📍 Little Rock📍 Castro Valley GT Medical Technologies, Inc. · Tests: GammaTile Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures NCT07493447EARLY Phase 11 site📍 Nashville Eben Rosenthal · Tests: Panitumumab-IRDye800 NK Cell Therapy for Malignant Solid Brain Tumors NCT07552233NA4 sites📍 Beijing📍 Qinhuangdao📍 Zhengzhou Peking University Third Hospital · Tests: Autologous NK cells Multicenter Trial on Surgical Outcome and Quality of Life in Juxta-medullary Tumors NCT07056023n/a1 site📍 Münster University Hospital Muenster Neurocognitive Impact of Different Irradiation Modalities for Patients With Grade I-II Skull Base Meningioma: NCT06036706NA3 sites📍 Caen📍 Le Havre📍 Rouen Centre Francois Baclesse · Tests: Normo-fractionated intensity-modulated brain irradiation with or without stereotactic positioning, Hypo-fractionated st… Treatment of Recurrent or Progressive Meningiomas With the Radiolabelled Somatostatin Antagonist 177Lu-satoreotide NCT04997317Phase 1, Phase 21 site📍 Basel University Hospital, Basel, Switzerland · Tests: 177Lu-DOTA-JR11 (Phase 0); Cycle 1 and Cycle 2 (cross-over), 177Lu-DOTATOC (Phase 0); Cycle 1 and Cycle 2 (cross-over),… Feasibility of Acquiring Hyperpolarized Imaging in Patients With Meningioma NCT06014905Phase 11 site📍 San Francisco Charlie Wang, MD, PhD · Tests: Hyperpolarized carbon C 13 pyruvate, Magnetic Resonance Image (MRI), Saline 177Lu-DOTATATE for Recurrent Meningioma NCT06326190Phase 219 sites📍 Innsbruck📍 Vienna📍 Lyon European Organisation for Research and Treatment of Cancer … · Tests: Local standard of Care, 177Lu-DOTATATE Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology NCT04648462n/a3 sites📍 Maastricht📍 Groningen📍 Delft Maastricht Radiation Oncology · Tests: ProTRAIT Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). NCT06607692Phase 1, Phase 21 site📍 Boadilla del Monte Fundación de investigación HM · Tests: Olaparib; 177Lu-DOTATATE Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial NCT06132685Phase 21 site📍 Atlanta Emory University · Tests: Biospecimen Collection, Computed Tomography, Dexamethasone, Magnetic Resonance Imaging, Questionnaire Administration Embolization for Meningioma NCT05416567NA1 site📍 Trondheim St. Olavs Hospital · Tests: Endovascular embolization Cabozantinib for Patients With Recurrent or Progressive Meningioma NCT05425004Phase 23 sites📍 Miami📍 New York📍 Nashville Baptist Health South Florida · Tests: Cabozantinib The Impact of Endoscopic Endonasal Skull Base Surgery on Olfaction NCT06874426n/a3 sites📍 Leuven📍 Frankfurt am Main📍 Leiden Universitaire Ziekenhuizen KU Leuven · Tests: Endoscopic endonasal skull base surgery Translation and Validation of the MQOL Self-questionnaire Into French for Assessing Quality of Life in Patients With Meningiomas NCT07044076n/a1 site📍 Paris Centre Hospitalier St Anne · Tests: Quality of life Apatinib in the Treatment of Recurrent Atypical/malignant Meningioma in Adults NCT04501705NA1 site📍 Beijing Beijing Sanbo Brain Hospital · Tests: Apatinib Mesylate NEO100 and High-Grade Meningioma NCT05023018Phase 25 sites📍 Los Angeles📍 San Francisco📍 Santa Monica Neonc Technologies, Inc. · Tests: NEO100 HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer) NCT06930846NA1 site📍 Lebanon Dartmouth-Hitchcock Medical Center · Tests: HOBSCOTCH-CA Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma NCT06557512NA1 site📍 San Francisco University of California, San Francisco · Tests: Hypofractionated Stereotactic Radiosurgery (SRS), Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Robot-Assisted Neurovascular Intervention NCT06752096NA1 site📍 Seoul Navigantis Inc. · Tests: cerebral angiography, arterial embolization, thrombectomy, Cerebral angiogram using robotic device, Meningioma emboliza… A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma NCT07428616Phase 220 sites📍 Birmingham📍 Phoenix📍 San Francisco Exelixis · Tests: Zanzalintinib Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy NCT04082520Phase 21 site📍 Rochester Mayo Clinic · Tests: Gallium Ga 68-DOTATATE, Lutetium Lu 177 Dotatate, Magnetic Resonance Imaging, Positron Emission Tomography, Questionnai… Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study NCT04278118NA1 site📍 Atlanta Emory University · Tests: Hypofractionated Radiation Therapy, Photon Beam Radiation Therapy, Proton Beam Radiation Therapy, Quality-of-Life Asses… SeOuL cOhort of Brain Tumor MONitoring Study (SOLOMON) NCT05254197n/a1 site📍 Seoul Seoul National University Hospital Comparison of Skin Closure Techniques in Oncological Neurosurgical Procedures: Intradermal Running Suture Versus Transdermal Interrupted Sutures NCT07413796NA1 site📍 Warsaw Medical University of Warsaw · Tests: Absorbable running intradermal suture, Non-absorbable interrupted transdermal suture Intraoperative Brain Shift Calculation Study NCT05477680NA1 site📍 Moscow Sklifosovsky Institute of Emergency Care · Tests: Navigation-guided surgery Pharmacoscopy for Patients With Refractory Primary Brain Tumors NCT06804655Phase 23 sites📍 Basel📍 Sankt Gallen📍 Zurich University of Zurich · Tests: Pharmacoscopy 1.0 Sonography-guided Resection of Brain Mass Lesions NCT05484245NA1 site📍 Moscow Sklifosovsky Institute of Emergency Care · Tests: Sonography RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma NCT07150806Phase 1, Phase 21 site📍 Columbus Joshua Palmer · Tests: Actinium Ac 225 DOTATATE RYZ101, Biospecimen Collection, Computed Tomography, Echocardiography Test, Gallium Ga 68-DOTA… A Dual-targeting Tracer TATE-RGD for the Diagnosis of SSTR- and RGD- Positive Tumors NCT06632860EARLY Phase 11 site📍 Beijing Peking Union Medical College Hospital · Tests: 68Ga-TATE-RGD, 18-FDG
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy